Watchlist Price Alert

Cadrenal Therapeutics Inc... (CVKD)

NASDAQ: CVKD · Real-Time Price · USD

13.14

0.01 (0.08%)

At close: Jun 17, 2025, 3:59 PM

Cadrenal Therapeutics Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022
Cash & Equivalents	7.34M	10.02M	4.36M	5.04M	6.57M	8.4M	9.11M	3.23M	4.03M	32.59K	103.08K	59.65K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	3.79K	3.79K	3.79K	175.18K	171.63K	3.79K	3.79K	3.79K	3.79K	-526.01K	2.19K	2.19K
Receivables	24.66K	38.15K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	584.06K	14.45K	308.59K	n/a	n/a	n/a	n/a	n/a	n/a	672.29K	414.24K	153.81K
Total Current Assets	7.94M	10.11M	4.67M	5.27M	6.86M	8.49M	9.28M	3.52M	4.44M	727.6K	541.36K	241.15K
Property-Plant & Equipment	4.68K	6.94K	3.01K	9.88K	16.61K	23.29K	29.78K	36.1K	39K	44.59K	1.77K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	8.47K	10.74K	6.8K	185.05K	188.25K	27.08K	33.57K	39.89K	42.79K	50.58K	3.97K	2.19K
Total Assets	7.95M	10.12M	4.68M	5.46M	7.05M	8.52M	9.31M	3.56M	4.48M	778.17K	545.32K	243.35K
Account Payables	1.28M	1.5M	496.82K	759.52K	400.37K	167.32K	141.66K	78.14K	119.57K	404.9K	308.22K	207.5K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	8.8K	n/a	21.35K	24.99K	24.06K	n/a	43.73K	n/a	n/a
Other Current Liabilities	561.76K	966.58K	767.89K	428.23K	230.87K	574.78K	330.54K	210.8K	170.28K	605.29K	n/a	n/a
Total Current Liabilities	1.84M	2.68M	1.27M	1.46M	856.32K	826.88K	563.57K	374.31K	401.63K	1.33M	672.36K	339.71K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	553.34K	528.47K	424.96K
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.42M	524.31K	149.52K
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	2.23K	8.8K	15.17K	4.99M	1.05M	574.48K
Total Liabilities	1.84M	2.68M	1.27M	1.46M	856.32K	826.88K	565.8K	383.1K	416.8K	6.33M	1.73M	914.18K
Total Debt	n/a	n/a	2.23K	8.8K	15.17K	21.35K	27.22K	32.86K	38.33K	640.71K	528.47K	424.96K
Common Stock	1.91K	1.78K	1.23K	16.01K	16.01K	13.02K	13.02K	11.72K	11.72K	8.19K	8.13K	7.95K
Retained Earnings	-29.57M	-25.72M	-21.54M	-19.13M	-16.73M	-15.07M	-13.93M	-12.89M	-11.89M	-6.71M	-1.7M	-678.79K
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	6.11M	7.44M	3.41M	3.99M	6.19M	7.69M	8.75M	3.18M	4.07M	-5.55M	-1.18M	-670.84K
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a